Axogen, Inc. Reports 2018 Fourth Quarter and Full Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AxoGen, Inc. (AXGN) PT Lowered to $35 at Jefferies
February 27, 2019 9:05 AM ESTJefferies analyst Raj Denhoy lowered the price target on AxoGen, Inc. (NASDAQ: AXGN) to $35.00 (from $45.00) while maintaining a Buy rating.
... MoreAxoGen (AXGN) Misses Q4 EPS by 4c
February 26, 2019 4:04 PM ESTAxoGen (NASDAQ: AXGN) reported Q4 EPS of ($0.09), $0.04 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $23.4 million versus the consensus estimate of $23.79 million.
We continue to see momentum in our core trauma, oral and maxillofacial, and breast reconstruction neurotization markets,... More
